Connect with us

Disability digest

Overpricing of Orthopedic Aids in Argentina – Criminal Scheme?

Objavljeno

/

Fotografija prikazuje osobu koja sjedi u invalidskim kolicima na otvorenom prostoru. U fokusu su donji dio kolica i noge osobe. Osoba nosi traperice i crne sportske tenisice s plavim i sivim detaljima. Veliki stražnji kotač sa žbicama i manji prednji kotačić jasno su vidljivi, kao i oslonac za noge s remenom koji stabilizira potkoljenicu. U pozadini se vidi popločena površina te travnati dio s grmljem i drvećem, što daje dojam mirnog, vanjskog okruženja.
Photo: Pixabay

The Argentine government has launched an investigation after an internal audit by the Ministry of Health uncovered evidence of potentially massive overpricing in the procurement of orthopedic and medical aids for persons with disabilities

Listen to the article

At the center of the case is Argentina’s National Disability Agency (ANDIS), which purchased wheelchairs, walkers, prosthetic limbs, and other assistive devices throughout 2025.

According to the audit, some suppliers charged the government prices many times higher than market value. In most of the reviewed cases, the price differences ranged from 300 to 1,000 percent, while some products exceeded 2,000 percent. The most striking example involved a walker that was purchased at a price 4,239 percent above its estimated market value.

Wheelchair procurement has drawn particular scrutiny. In several instances, the government reportedly paid several times the market price for wheelchairs, with auditors concluding that the discrepancies could not be justified by technical specifications or the individual needs of users.

The Ministry of Health compared suppliers’ invoices with market prices and forwarded its findings to judicial authorities. The investigation now involves several companies that participated in public procurement processes, as well as former officials connected to ANDIS. Argentine media report that several individuals, including former agency executives and representatives of supplier companies, have already been charged.

According to information published by Argentine media, the contracts under review are worth approximately 18 billion Argentine pesos. Auditors suspect that some tenders may have been tailored to pre-selected suppliers, allowing prices to be artificially inflated through the public procurement system.

The case has attracted widespread public attention because it concerns equipment intended for persons with disabilities—a group that often depends on timely access to high-quality assistive devices in order to live independently.

Critics warn that any irregularities in the procurement system directly affect people whose wheelchairs, prostheses, and other assistive technologies are essential for daily life and social inclusion.

The investigation is still ongoing, and authorities have yet to determine whether the disputed contracts resulted from administrative failures or an organized corruption network. Regardless of the outcome, the case raises a broader question that also concerns many people with disabilities: how realistic are the prices of orthopedic aids?

In the end, it makes little difference whether the bill is paid directly by citizens or by the state—because public money belongs to the public.

Disability digest

Trump Raises Concerns Among Immigrants With Disabilities

Objavljeno

/

Napisao/la:

Dvostruka ekspozicija prikazuje govor uz podignutu šaku preko zida od opeke.
Photo: Pixabay

A new policy introduced by the administration of U.S. President Donald Trump could make it significantly more difficult for people with disabilities to immigrate to the United States and may discourage immigrant families from using healthcare and other public benefits to which they are legally entitled, disability rights organisations warn

Listen to the article

The U.S. Department of Homeland Security (DHS) has adopted a rule expanding the circumstances under which people applying for visas or permanent residency may be considered a “public charge.”

Such a determination can result in an immigration application being denied if authorities conclude that the individual is likely to become dependent on government assistance over the long term.

Disability advocates are particularly concerned that immigration officials may take applicants’ health conditions and functional limitations into account when making these assessments. Organisations representing people with disabilities warn that individuals who require long-term medical care or various forms of support could therefore face greater disadvantages during the immigration process.

Experts say the consequences could extend well beyond immigration proceedings themselves. They point to the so-called “chilling effect,” in which people avoid using public programmes out of fear that doing so could jeopardise their immigration status, even when they are legally entitled to those services.

A similar pattern was observed during President Trump’s first administration after a comparable public charge rule was introduced.

Families in which children are U.S. citizens but their parents are immigrants are expected to be particularly affected. Disability rights advocates warn that parents may avoid enrolling their children in Medicaid or other healthcare programmes because they fear this could negatively affect future visa or permanent residency applications, even though participation in certain programmes should not, in many cases, have such consequences.

Organisations providing legal assistance to immigrants also warn that the complexity of the new rules will make it difficult for many families to understand what is and is not permitted. As a result, they expect some people to forgo healthcare, rehabilitation services or other forms of assistance as a precaution, potentially leading to serious consequences for their health and quality of life.

Representatives of disability rights organisations argue that the new rule creates additional barriers for people who already face challenges in accessing education, employment and healthcare because of their health conditions or disabilities.

They maintain that immigration decisions should be based on established legal criteria rather than assumptions about potential future healthcare or social service costs.

Nastavite čitati

Disability digest

EXPERIMENTAL DRUG A Breakthrough in Epilepsy Treatment?

Objavljeno

/

Napisao/la:

Plastična tjedna kutija za organizaciju lijekova nalazi se u pozadini, dok su u prvom planu blister pakiranja s tabletama različitih oblika. Fotografija simbolizira redovito uzimanje terapije i organizaciju lijekova.
Photo: Pixabay

For some patients, epileptic seizures have been reduced by an astonishing 90%, significantly improving their ability to carry out everyday activities while restoring their confidence and quality of life

Listen to the article

An antisense oligonucleotide (ASO) drug is still undergoing clinical trials and is awaiting approval from the U.S. Food and Drug Administration (FDA). Even so, it has already generated considerable optimism and hope among people living with epilepsy.

ASO works cumulatively, and its developers stress that it is not a universal cure for epilepsy. Nevertheless, patients who have received the treatment describe its effects as remarkable. The drug is administered directly into the spinal canal, and as its effects gradually diminish between doses, some symptoms may temporarily return.

What is particularly encouraging is that, in some patients, epileptic seizures have been reduced by as much as 90%. Many have become far more capable of managing everyday tasks and have regained confidence and a renewed sense of purpose.

One such patient is 17-year-old American Connor Dalby, who was previously unable to walk. After receiving the experimental treatment, he gained the ability to run. However, he continues to live with a severe form of autism spectrum disorder and developmental and epileptic encephalopathy, a rare type of epilepsy.

Connor is still unable to speak independently and, although he can now stand and move around on his own, he often requires guidance from his caregivers. He continues to need full-time care, but his condition has improved dramatically compared with before he began receiving the treatment.

Connor is among a small number of patients granted access to the experimental therapy through an FDA-authorised expanded access programme while the drug remains in clinical testing.

In simple terms, the experimental treatment reduces the activity of the mutated gene responsible for causing epilepsy while preserving the function of the healthy copy of the gene. Researchers believe that this ability to suppress the harmful genetic signal while maintaining the beneficial one could potentially be applied to patients with a wide range of disease-causing mutations.

Identifying these mutations shortly after birth and beginning treatment as early as possible may help children avoid developmental impairments caused by persistent epileptic seizures.

Nastavite čitati

Disability digest

Autism Training Crucial in Rescue of Missing Three-Year-Old

Objavljeno

/

Napisao/la:

Dvije djelatnice rade za računalima sa slušalicama.
Photo: Pexels

Specialised autism training received by an emergency dispatcher played a crucial role in locating a three-year-old boy with autism who wandered away from his home in the U.S. state of Ohio. The case highlights how understanding the characteristics of autism can be vital during searches for missing children

Listen to the article

When the boy’s mother reported her three-year-old son missing, emergency dispatcher Rebecca Elias immediately recognised that the situation required a different approach from the standard protocol.

Thanks to the training she had previously completed, Elias asked several questions that would not normally be included in a routine emergency call. In particular, she wanted to know whether there were any swimming pools, lakes or other bodies of water near the family’s home.

Police officers and rescue teams were immediately directed to a nearby swimming pool, where the boy was found alive and safely rescued.

Rebecca Elias completed a training programme provided by the National Center for Missing & Exploited Children (NCMEC). The programme is designed for emergency dispatchers, law enforcement officers and other first responders to help them better understand the behaviour of people on the autism spectrum during emergency situations.

According to NCMEC guidance, children with autism who wander away often do not respond when called by name, may avoid contact with rescuers, or may be drawn to specific places or objects. The organisation also warns that bodies of water present one of the greatest dangers during such incidents, as drowning is the leading cause of death among children with autism who wander.

For this reason, emergency responder training focuses on recognising behavioural patterns commonly associated with autism and adapting search strategies to the specific needs of individuals on the autism spectrum.

Following the successful rescue, Rebecca Elias said that the training enabled her to ask the right questions immediately and direct the search in a way that ultimately led to a positive outcome.

Nastavite čitati

Tko su Purger i Purgerica?

Purger i Purgerica

U trendu